Teslexivir

CAS No. 1075798-37-6

Teslexivir( BTA074 | BTA-074 | AP611074 | AP-611074 )

Catalog No. M10309 CAS No. 1075798-37-6

A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1323 Get Quote
50MG 2682 Get Quote
100MG 3600 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Teslexivir
  • Note
    Research use only, not for human use.
  • Brief Description
    A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.
  • Description
    A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11; is being evaluated as a topical treatment for genital warts, condyloma or other HPV infections.HPV Infection Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BTA074 | BTA-074 | AP611074 | AP-611074
  • Pathway
    Microbiology/Virology
  • Target
    HPV
  • Recptor
    HPV
  • Research Area
    Infection
  • Indication
    HPV Infection

Chemical Information

  • CAS Number
    1075798-37-6
  • Formula Weight
    642.594
  • Molecular Formula
    C35H36BrN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)C1=CC(Br)=C(CC(NN(C2=CC=C(CC3=CC=CC=C3)C=C2)C4=C(N5CCCCC5)C=CC=C4C)=O)C=C1OC
  • Chemical Name
    4-(2-{2-(4-benzylphenyl)-2-[2-methyl-6-(piperidin-1-yl)phenyl]hydrazin-1-yl}-2-oxoethyl)-5-bromo-2-methoxybenzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HPV16 E7 (86-93)

    This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be used in vaccines for the prevention and treatment of cervical carcinoma.

  • HPV16-E711-20 epitop...

    HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro.

  • Teslexivir

    A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.